Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Hepciwel Tablets
Hepciwel Tablets provide a powerful option in the fight against chronic hepatitis C infection (HCV). With Sofosbuvir 400mg, this advanced antiviral medication inhibits viral replication and helps patients achieve a sustained virologic response, improving liver health and quality of life.
Uses of Hepciwel Tablets
Treatment of chronic hepatitis C infection (HCV)
Effective against multiple HCV genotypes (1–6)
Helps reduce viral load, promoting a cure in many patients
Used in combination with other antiviral agents for optimal outcomes
Benefits of Hepciwel Tablets
Highly effective antiviral action against HCV
Well-tolerated with a low incidence of severe side effects
Proven to achieve SVR, often resulting in undetectable HCV levels
Reduces the risk of liver complications such as cirrhosis and liver cancer
Convenient once-daily dosing as part of a combination therapy regimen
Mechanism of Action of Hepciwel Tablets
Inhibits the HCV NS5B RNA-dependent RNA polymerase, stopping the virus from replicating.
Reduces viral load rapidly, helping the body clear the infection when used with other DAAs.
Prevents progression of liver damage, improving liver function and long-term health.